Focus

Pfizer CEO

LATEST

EpochTV Live
EpochTV Live

Reuters Interviews Pfizer CEO Albert Bourla

Reuters Interviews Pfizer CEO Albert Bourla
|
Companies
Companies

Pfizer Plans to Hike Price of US COVID-19 Vaccine by 400 Percent

Pfizer Plans to Hike Price of US COVID-19 Vaccine by 400 Percent
|
Australia News
Australia News

‘Global Collaboration’: Victorian Government in Agreement with Pfizer

‘Global Collaboration’: Victorian Government in Agreement with Pfizer
|
Vaccines & Safety
Vaccines & Safety

Pfizer CEO Hopes for Annual COVID-19 Vaccine Over More Frequent Boosters

Pfizer CEO Hopes for Annual COVID-19 Vaccine Over More Frequent Boosters
|
Vaccines & Safety
Vaccines & Safety

Pfizer CEO Says an Omicron-Targeted Vaccine Will Be Ready in March

Pfizer CEO Says an Omicron-Targeted Vaccine Will Be Ready in March
|
Vaccines & Safety
Vaccines & Safety

Pfizer Seeks FDA Authorization for COVID-19 Booster Shots in 16- and 17-Year-Olds

Pfizer Seeks FDA Authorization for COVID-19 Booster Shots in 16- and 17-Year-Olds
|
Expert View
Expert View

Pfizer CEO Predicts Vaccine-Resistant COVID-19 Variant Likely to Emerge

Pfizer CEO Predicts Vaccine-Resistant COVID-19 Variant Likely to Emerge
|
EpochTV Live
EpochTV Live

Reuters Interviews Pfizer CEO Albert Bourla

Reuters Interviews Pfizer CEO Albert Bourla
|
Companies
Companies

Pfizer Plans to Hike Price of US COVID-19 Vaccine by 400 Percent

Pfizer Plans to Hike Price of US COVID-19 Vaccine by 400 Percent
|
Australia News
Australia News

‘Global Collaboration’: Victorian Government in Agreement with Pfizer

‘Global Collaboration’: Victorian Government in Agreement with Pfizer
|
Vaccines & Safety
Vaccines & Safety

Pfizer CEO Hopes for Annual COVID-19 Vaccine Over More Frequent Boosters

Pfizer CEO Hopes for Annual COVID-19 Vaccine Over More Frequent Boosters
|
Vaccines & Safety
Vaccines & Safety

Pfizer CEO Says an Omicron-Targeted Vaccine Will Be Ready in March

Pfizer CEO Says an Omicron-Targeted Vaccine Will Be Ready in March
|
Vaccines & Safety
Vaccines & Safety

Pfizer Seeks FDA Authorization for COVID-19 Booster Shots in 16- and 17-Year-Olds

Pfizer Seeks FDA Authorization for COVID-19 Booster Shots in 16- and 17-Year-Olds
|
Expert View
Expert View

Pfizer CEO Predicts Vaccine-Resistant COVID-19 Variant Likely to Emerge

Pfizer CEO Predicts Vaccine-Resistant COVID-19 Variant Likely to Emerge
|